➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Last Updated: October 26, 2021

DrugPatentWatch Database Preview

Brincidofovir - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

What are the generic drug sources for brincidofovir and what is the scope of freedom to operate?

Brincidofovir is the generic ingredient in one branded drug marketed by Chimerix and is included in two NDAs. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Brincidofovir has forty-eight patent family members in fifteen countries.

Summary for brincidofovir

International Patents:	48
US Patents:	5
Tradenames:	1
Applicants:	1
NDAs:	2
Raw Ingredient (Bulk) Api Vendors:	20
Clinical Trials:	11
Patent Applications:	463
DailyMed Link:	brincidofovir at DailyMed

Recent Clinical Trials for brincidofovir

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
SymBio Pharmaceuticals	Phase 1
Food and Drug Administration (FDA)	Phase 2
Chimerix	Phase 2

See all brincidofovir clinical trials

US Patents and Regulatory Information for brincidofovir

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Free Forever Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Chimerix	TEMBEXA	brincidofovir	SUSPENSION;ORAL	214460-001	Jun 4, 2021		RX	Yes	Yes	⤷ Free Forever Trial	⤷ Free Forever Trial				⤷ Free Forever Trial
Chimerix	TEMBEXA	brincidofovir	TABLET;ORAL	214461-001	Jun 4, 2021		RX	Yes	Yes	⤷ Free Forever Trial	⤷ Free Forever Trial	Y	Y		⤷ Free Forever Trial
Chimerix	TEMBEXA	brincidofovir	TABLET;ORAL	214461-001	Jun 4, 2021		RX	Yes	Yes	⤷ Free Forever Trial	⤷ Free Forever Trial				⤷ Free Forever Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for brincidofovir

Subscribe to access the full database, or Free Forever Trial
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2015073148	⤷ Free Forever Trial
Japan	2017200919	⤷ Free Forever Trial
Russian Federation	2013114370	⤷ Free Forever Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.